期刊文献+

甲状腺功能亢进症的治疗现状与展望 被引量:11

Current situation and prospects of management of hyperthyroidism
下载PDF
导出
摘要 介绍了甲状腺功能亢进症的治疗现状及临床研究新进展。目前,治疗甲亢的基本方法仍然是抗甲状腺药物应用。经药物治疗后复发、甲状腺明显肿大且伴有甲亢心及肝功能损害、中老年甲亢应积极采取131I治疗。甲状腺巨大、结节性甲状腺肿伴甲亢、甲亢合并甲状腺结节不能除外恶性者应积极采取手术治疗。根据患者的病情合理选择不同的治疗方法可获得良好治疗效果。 The current situation and recent clinical progress of management of hyperthyroidism are introduced. The basic treatment for hyperthyroidism is antithyroid drugs. However, radioiodine should be administered in patients with relapse after treatment with antithyroid drugs, significantly enlarged thyroid with thyrotoxic heart disease or hepatic function impairment, or elder patients. Besides, thyromegaly, nodular goiter, or suspected malignant thyroid nodule should be managed with surgical treatment actively. It can achieve favorable results to choose the individualized treatment according to the patient's condition.
作者 施秉银
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第4期361-364,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 甲状腺功能亢进症 抗甲状腺药物 放射性碘 手术 hyperthyroidism antithyroid drug radioiodine operation
  • 相关文献

参考文献28

  • 1Escobar-Morreale HF, Serrano-Cotarredona J, Villar LM, et al. Methimazole has no dose-related effect on the serum concentra-tions of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and beta-microglobulin in patients with Graves' disease [J]. Thyroid, 1996, 6(1):29-36. 被引量:1
  • 2Humar M, Dohrmann H, Stein P, et al. Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Racl and inhibitor of kappaB kinase alpha[J]. J Pharmacol Exp Ther, 2008, 324(3):1037-1044. 被引量:1
  • 3Wartofsky L. Low remission after therapy for Graves' disease; Possible relation of dietary iodine with antithyroid therapy resuits [J]. J Amer Med Assn, 1973, 226(9) :1083-1088. 被引量:1
  • 4Hedley A.I, Young RE, Jones SJ, et al. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: Long-term follow-up of 434 patients [J]. Clin Endocrinol, 1989, 31(2): 209-218. 被引量:1
  • 5Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment [J]. Thyroid, 1997, 7(3):639-675. 被引量:1
  • 6Liu XJ, Shi BY, Li H. Valuable features for predicing the remission of Graves hyperthyroidism after antithyroid drug trearmerit [J]. Thyroid, 2006, 16(9) :875. 被引量:1
  • 7Young ET, Steel NR, Taylor JJ, et al. Prediction of remission after antithyroid drug treatment in Graves' disease [J]. Q J Med, 1988, 66(250):175-189. 被引量:1
  • 8Shizume K. Long term antithyroid drug therapy for intractable cases of Graves' disease [J]. Endoerinol Jpn, 1978, 25(4) :377-379. 被引量:1
  • 9Laurberg P. Remission of Graves' disease during anti-thyroid drug therapy; Time to reconsider the mechanism [J]? Eur J of Endocrinol, 2006, 155(6);783-786. 被引量:1
  • 10施秉银.甲状腺疾病危象的诊断与治疗[J].国外医学(内分泌学分册),2005,25(2):143-144. 被引量:18

二级参考文献25

  • 1连小兰,白耀,戴为信,金自孟,曾正陪,郭芝生.丙硫氧嘧啶导致症状性肝损伤的临床特征及相关因素分析[J].中华内科杂志,2004,43(6):442-446. 被引量:22
  • 2武敏,施秉银.Graves病动物模型研究进展[J].陕西医学杂志,2006,35(3):321-323. 被引量:1
  • 3施秉银.甲状腺功能亢进症.见:施秉银,马秀萍,主编.现代甲状腺诊断与治疗.西安:陕西科学技术出版社,1998,3-24. 被引量:2
  • 4Huang M J,Li KL,Wei JS,et al.Sequential liver and bone biochemical changes in hyperthyroidism:prospective controlled follow-up study[J].Am J Gastroenterol,1994,89 (7):1071-1074. 被引量:1
  • 5Aydemir S,Bayraktaroglu T,Demircan N,et al.Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests[J].IntJ Clin Pract,2005,59 (11):1304-1308. 被引量:1
  • 6Greenberger NJ,Milligan FD,DeGroot LJ,et al.Jaundice and thyrotoxicosis in the absence of congestive heart failure[J].Am J Med,1964,36:840-846 被引量:1
  • 7Yao JD,Gross JB,Ludwig J,et al.Chelestatic jaundice in hyperthyroidism[J].Am J Med,1989,86:619-620. 被引量:1
  • 8Hasan MK,Tierney WM,Baker MZ.Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine[J].Am J Med Sci,2004,328 (6):348 -350. 被引量:1
  • 9Vitug AC,Goldman JM.Hepatotoxicity from antithyroid drugs[J].HormRes,1985,21 (4):229-234. 被引量:1
  • 10Williams KV,Nayak S,Becker D,et al.Fifty years of experience with propylthiouracil-associated hepatotoxicity:what we learned[J]? J Clin Endocrinol Metab,1997,82 (6):1727-1733. 被引量:1

共引文献56

同被引文献110

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部